Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Patients on the waiting list for liver transplantation with liver cancer, with any etiology
- Effort will be made to enroll at least 2/3 of patients who have had chronic HCV infection and prior treatment with direct acting antivirals with HCV eradication.
- Children aged <18 years of age